OSE Immunotherapeutics Future Growth
Future criteria checks 3/6
OSE Immunotherapeutics is forecast to grow earnings and revenue by 33.8% and 57.4% per annum respectively while EPS is expected to grow by 33.7% per annum.
Key information
33.8%
Earnings growth rate
33.7%
EPS growth rate
Biotechs earnings growth | 27.9% |
Revenue growth rate | 57.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 16 May 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 75 | 37 | 43 | 43 | 1 |
12/31/2024 | N/A | -45 | -39 | -39 | 1 |
12/31/2023 | N/A | -44 | -38 | -38 | 1 |
12/31/2022 | 18 | -18 | -19 | -18 | N/A |
9/30/2022 | 26 | -13 | -12 | -12 | N/A |
6/30/2022 | 33 | -7 | -6 | -5 | N/A |
3/31/2022 | 30 | -12 | -8 | -8 | N/A |
12/31/2021 | 26 | -17 | -10 | -10 | N/A |
9/30/2021 | 20 | -21 | -14 | -13 | N/A |
6/30/2021 | 14 | -25 | -17 | -17 | N/A |
3/31/2021 | 12 | -21 | -18 | -18 | N/A |
12/31/2020 | 10 | -17 | -20 | -20 | N/A |
9/30/2020 | 13 | -12 | -17 | -17 | N/A |
6/30/2020 | 16 | -8 | -14 | -14 | N/A |
3/31/2020 | 21 | -6 | -3 | -2 | N/A |
12/31/2019 | 26 | -5 | 9 | 9 | N/A |
9/30/2019 | 23 | -4 | 8 | 9 | N/A |
6/30/2019 | 20 | -3 | 8 | 8 | N/A |
3/31/2019 | 22 | 1 | 4 | 5 | N/A |
12/31/2018 | 24 | 5 | 0 | 1 | N/A |
9/30/2018 | 24 | 5 | -1 | 0 | N/A |
6/30/2018 | 24 | 5 | -3 | -2 | N/A |
3/31/2018 | 16 | -3 | -5 | -5 | N/A |
12/31/2017 | 7 | -11 | -8 | -8 | N/A |
9/30/2017 | 5 | -10 | -2 | -2 | N/A |
6/30/2017 | 3 | -10 | 4 | 4 | N/A |
3/31/2017 | 2 | 5 | 2 | 2 | N/A |
12/31/2016 | 0 | 21 | 1 | 1 | N/A |
9/30/2016 | 0 | 21 | N/A | -2 | N/A |
6/30/2016 | 0 | 22 | N/A | -5 | N/A |
3/31/2016 | 0 | 8 | N/A | -5 | N/A |
12/31/2015 | 0 | -6 | N/A | -5 | N/A |
9/30/2015 | 0 | -5 | N/A | -4 | N/A |
6/30/2015 | 0 | -5 | N/A | -3 | N/A |
3/31/2015 | 0 | -4 | N/A | -3 | N/A |
12/31/2014 | N/A | -3 | N/A | -2 | N/A |
9/30/2014 | N/A | -2 | N/A | -1 | N/A |
6/30/2014 | N/A | -1 | N/A | -1 | N/A |
3/31/2014 | N/A | -1 | N/A | 0 | N/A |
12/31/2013 | N/A | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OSEP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.2%).
Earnings vs Market: OSEP is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: OSEP is expected to become profitable in the next 3 years.
Revenue vs Market: OSEP is forecast to have no revenue next year.
High Growth Revenue: OSEP is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OSEP's Return on Equity is forecast to be high in 3 years time